2024-05-01 2025-04-30 false Capium Accounts Production 1.1 02416128 2024-05-01 2025-04-30 02416128 bus:AbridgedAccounts 2024-05-01 2025-04-30 02416128 bus:FRS102 2024-05-01 2025-04-30 02416128 bus:AuditExemptWithAccountantsReport 2024-05-01 2025-04-30 02416128 bus:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 02416128 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 02416128 2024-05-01 2025-04-30 02416128 2025-04-30 02416128 bus:RegisteredOffice 2024-05-01 2025-04-30 02416128 core:WithinOneYear 2025-04-30 02416128 core:AfterOneYear 2025-04-30 02416128 1 2024-05-01 2025-04-30 02416128 bus:Director1 2024-05-01 2025-04-30 02416128 bus:Director1 2025-04-30 02416128 bus:Director1 2023-05-01 2024-04-30 02416128 2023-05-01 02416128 bus:LeadAgentIfApplicable 2024-05-01 2025-04-30 02416128 2023-05-01 2024-04-30 02416128 2024-04-30 02416128 core:WithinOneYear 2024-04-30 02416128 core:AfterOneYear 2024-04-30 02416128 bus:EntityAccountantsOrAuditors 2023-05-01 2024-04-30 02416128 core:PlantMachinery 2024-05-01 2025-04-30 02416128 core:PlantMachinery 2025-04-30 02416128 core:PlantMachinery 2024-04-30 02416128 core:FurnitureFittings 2024-05-01 2025-04-30 02416128 core:FurnitureFittings 2025-04-30 02416128 core:FurnitureFittings 2024-04-30 02416128 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-04-30 02416128 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-04-30 02416128 core:CostValuation core:Non-currentFinancialInstruments 2025-04-30 02416128 core:CostValuation core:Non-currentFinancialInstruments 2024-04-30 02416128 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-04-30 02416128 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-04-30 02416128 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-04-30 02416128 core:Non-currentFinancialInstruments 2025-04-30 02416128 core:Non-currentFinancialInstruments 2024-04-30 02416128 core:ShareCapital 2025-04-30 02416128 core:ShareCapital 2024-04-30 02416128 core:RetainedEarningsAccumulatedLosses 2025-04-30 02416128 core:RetainedEarningsAccumulatedLosses 2024-04-30 02416128 dpl:Item1 2024-05-01 02416128 dpl:Item1 2025-04-30 02416128 dpl:Item1 2023-05-01 02416128 dpl:Item1 2024-04-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 02416128
England and Wales

 

 

 

PROTECH MEDICAL LIMITED



Abridged Accounts
 


Period of accounts

Start date: 01 May 2024

End date: 30 April 2025
 
 
Notes
 
2025
£
  2024
£
Fixed assets      
Tangible fixed assets 3 117,488    94,758 
117,488    94,758 
Current assets      
Stocks 82,991    87,728 
Debtors 71,472    67,055 
Cash at bank and in hand 86,680    85,697 
241,143    240,480 
Creditors: amount falling due within one year (132,258)   (151,505)
Net current assets 108,885    88,975 
 
Total assets less current liabilities 226,373    183,733 
Creditors: amount falling due after more than one year 2   
Provisions for liabilities (22,323)   (18,004)
Net assets 204,052    165,729 
 

Capital and reserves
     
Called up share capital 100    100 
Profit and loss account 203,952    165,629 
Shareholders' funds 204,052    165,729 
 


For the year ended 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 18 July 2025 and were signed by:


-------------------------------
J N Ashton
Director
1
General Information
Protech Medical Limited is a private company, limited by shares, registered in England and Wales, registration number 02416128, registration address 74 Scotty Brook Cresent, Glossop, Derbyshire, SK13 8UG.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rate of exchange ruling at the statement of financial position date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All foreign exchange differences are included to the income statement.
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery 15% Reducing Balance
Fixtures and Fittings 15% Reducing Balance
Stocks
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Average number of employees

Average number of employees during the year was 2 (2024 : 2).
3.

Tangible fixed assets

Cost or valuation Plant and Machinery   Fixtures and Fittings   Total
  £   £   £
At 01 May 2024 61,238    323,844    385,082 
Additions 43,463      43,463 
Disposals    
At 30 April 2025 104,701    323,844    428,545 
Depreciation
At 01 May 2024 53,359    236,965    290,324 
Charge for year 7,701    13,032    20,733 
On disposals    
At 30 April 2025 61,060    249,997    311,057 
Net book values
Closing balance as at 30 April 2025 43,641    73,847    117,488 
Opening balance as at 01 May 2024 7,879    86,879    94,758 


2